AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

SARS-CoV-2 Testing: Selecting the Right Test for the Right Person

  • Credit:1.0 ACCENT Credit
  • Duration: 1 hour
  • Date:NOV.12.2020 1:30 PM - 02:30 PM
  • Level: Advanced

Price: $0.00

Member Price: $0.00

Register to view this On Demand webinar, recorded November 12, 2020, and learn how to select the correct test for SARS-CoV-2. With your registration, you will have access to the recording through November 30, 2021.

DESCRIPTION

Implementing the correct test at the appropriate time is crucial for SARS-CoV-2 diagnosis, public health surveillance, and limiting the spread of the virus. However, the frequent emergence of new assays, changes to regulations, and constantly revising guidelines may cause considerable confusion among laboratorians. This webinar will provide an overview of the diagnostic and serologic methods for SARS-CoV-2, their clinical utility, and how to effectively navigate the guidelines and regulations to implement appropriate SARS-CoV-2 testing.

TARGET AUDIENCE

This activity is designed for lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), point-of-care coordinators, and other laboratory professionals overseeing and/or carrying out sepsis testing.

LEARNING OBJECTIVES

At the end of this activity, participants will be able to:

  • Describe the principal differences in approaches to SARS-CoV-2 testing.
  • Apply the latest SARS-CoV-2 testing guidelines when considering the approach to testing.
  • Guide the selection of the appropriate SARS-CoV-2 test taking laboratory and patient factors into consideration.

FACULTY

Carey-Ann Burnham HeadshotCarey-Ann Burnham, PhD
Professor
Washington University School of Medicine
St. Louis, MO, USA

headshot Christopher Farnsworth Christopher Farnsworth, PhD
Instructor of Pathology and Immunology
Washington University School of Medicine
St. Louis, MO, USA

DISCLOSURES AND STATEMENT OF INDEPENDENCE

AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Cary-Ann Burnham, PhD

  • Grant/Research Support: Cepheid, Luminex, BioFire
  • Consultant Fee: Cepheid
  • Presenter/Speaker: BioFire, Medscape

Christopher Farnsworth, PhD

  • Grant/Research Support: Beckman Coulter, Abbott Diagnostics, NOWDiagnostics

CONTENT VALIDITY

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

ACCREDITATION STATEMENT

This activity is approved for 1.0 ACCENT credit(s) by AACC. Activity ID# 2041. This activity was planned in accordance with ACCENT Standards and Policies.

SUCCESSFUL COMPLETION STATEMENT

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

Supported By

Roche Logo